3//SEC Filing
Sun Pharma (Netherlands) B.V. 3
Accession 0000925421-17-000341
CIK 0001711279other
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 7:09 PM ET
Size
7.5 KB
Accession
0000925421-17-000341
Insider Transaction Report
Form 3
Sun Pharma (Netherlands) B.V.
10% Owner
Holdings
- 914,107
Series A Convertible Preferred Stock
Footnotes (1)
- [F1]The Series A convertible preferred stock will automatically convert on a one-to-one basis into 914,107 shares of common stock upon the closing of Krystal Biotech, Inc.'s initial public offering.
Issuer
Krystal Biotech, Inc.
CIK 0001711279
Entity typeother
IncorporatedNetherlands
Related Parties
1- filerCIK 0001717322
Filing Metadata
- Form type
- 3
- Filed
- Sep 18, 8:00 PM ET
- Accepted
- Sep 19, 7:09 PM ET
- Size
- 7.5 KB